Home › Funds › Logos Global Management LP › OLMA
Logos Global Management LP position in OLMA
OLEMA PHARMACEUTICALS INC · Health Care
Logos Global Management LP reported holding 3,208,875 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$40.1M, representing 1.73% of its reported portfolio and ranking #18 among its reported holdings. Logos Global Management LP has disclosed OLMA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's OLMA position evolved
Logos Global Management LP first disclosed a stake in OLMA in Q3 2023 at 3,743,875 shares (US$46.2M). The position peaked in Q4 2025 at 3,208,875 shares, worth US$80.2M. Across 12 filings, Logos Global Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 3,208,875 shares valued at US$40.1M. Notable position changes include a 27% trim in Q2 2024 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.74M | $46.24M | New |
| Q4 2023 | 4.38M | $54.38M | Add |
| Q1 2024 | 4.38M | $49.63M | Hold |
| Q2 2024 | 3.21M | $34.72M | Reduce |
| Q3 2024 | 3.21M | $38.31M | Hold |
| Q4 2024 | 3.21M | $18.71M | Hold |
| Q1 2025 | 3.21M | $12.07M | Hold |
| Q2 2025 | 3.21M | $13.67M | Hold |
| Q3 2025 | 3.21M | $31.41M | Hold |
| Q4 2025 | 3.21M | $80.22M | Hold |
| Q1 2026 | 3.21M | $47.84M | Hold |
| Q2 2026 | 3.21M | $40.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OLMA and 13F data
OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OLMA
- Paradigm Biocapital Advisors LP 8.67M sh · $108.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.09M sh · $88.64M · Q2 2026
- BVF INC/IL 5.30M sh · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M sh · $60.76M · Q2 2026
- Cormorant Asset Management, LP 2.15M sh · $26.90M · Q2 2026
- Lightspeed Management Company, L.L.C. 1.36M sh · $16.95M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M sh · $15.01M · Q2 2026
- Defilade Capital Management, L.P. 924.76K sh · $11.57M · Q2 2026
- Vivo Capital, LLC 671.84K sh · $8.40M · Q2 2026
- Jones Hill Capital LP 574.17K sh · $7.18M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held OLMA?
Logos Global Management LP has disclosed OLMA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Logos Global Management LP's current position in OLMA?
As of Q2 2026, Logos Global Management LP holds 3.21M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $40.14M, representing 1.73% of its reported portfolio and ranking #18.
Has Logos Global Management LP been buying or selling OLMA?
In the latest 13F filing (Q2 2026), Logos Global Management LP held unchanged its position in OLMA. The position peaked in Q4 2025 at 3.21M shares.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.